Clinical Innovations purchases Australian distributor JB Medical Supplies

Labor, delivery and neonatal intensive care devices company Clinical Innovations (Salt Lake City) has acquired Australian distributor JB Medical Supplies.

The deal, announced yesterday, is meant to bolster Clinical Innovations’ position in Australia. JB Medical Supplies will operate as a wholly owned subsidiary of Clinical Innovations.

Financial terms of the deal were not disclosed.

Get the full story on sister site Medical Design & Outsourcing.

The post Clinical Innovations purchases Australian distributor JB Medical Supplies appeared first on MassDevice.

AtriCure inks multi-year Chinese distro deal with Baheal Pharma

AtriCure (NSDQ:ATRC) said today it inked a multi-year partnership deal with China’s Baheal Pharmaceutical Group to distribute AtriCure’s surgical ablation devices.

Through the deal, Baheal will become Mason, Ohio-based AtriCure’s exclusive distributor in the region, replacing the company’s previous distribution partner.

“At Baheal, we’re continuously looking for ways to grow and expand our business. We believe that there is vast opportunity to treat patients and the market remains underpenetrated, and we’re confident that together, we are well positioned to grow and help more patients in China affected by atrial fibrillation,” Baheal Pharma chair Fu Gang said in a prepared statement.

AtriCure said that it hopes to pursue new product approvals in China over the next several years as it looks to bring its full portfolio of surgical ablation and left atrial appendage management devices into the Chinese market.

“We are pleased to have formed this new partnership with Baheal. With Baheal’s stellar reputation, their size and scale, combined with our market-leading devices, we are well positioned to establish a foundation for future growth in China,” AtriCure prez & CEO Michael Carrel said in a press release.

In April, AtriCure saw shares rise after the cardiovascular company’s first-quarter numbers showed a nearly 14% top-line gain and shaved a penny off its quarterly earnings loss.

The post AtriCure inks multi-year Chinese distro deal with Baheal Pharma appeared first on MassDevice.

Varian acquires Taiwanese distributor Cooperative CL Enterprises

Varian Medical (NYSE:VAR) said today it acquired Taiwanese radiotherapy equipment distributor Cooperative CL Enterprises for an undisclosed amount.

The distribution company, based in Taipei, currently employs approximately 45 individuals and has represented and distributed Varian equipment for more than 40 years, the Palo Alto, Calif.-based company said.

“With the acquisition of COOP, Varian will be able to work and collaborate more closely with our customers in Taiwan as well as providing more efficient and comprehensive services,” Varian Asia Pacific prez Kevin O’Reilly said in a prepared release.

“COOP has built a strong team in Taiwan. The team, led by Christina Lin as the new managing director of Varian Taiwan, is now able to directly access all Varian resources and tools for products and services. We hope to provide enhanced service for our customers and expand the access of quality and cost-effective cancer care solutions in Taiwan, as well as engage in more clinical research and collaborations with leading hospitals,” Varian regional manging director Xiao Zhang said in a press release.

“Since its founding, COOP has been focused on being the best partner for clinicians in the fight against cancer. We are committed to providing the most advanced solutions and comprehensive services for customers in Taiwan to save more lives. I believe by joining the Varian family and leveraging its global network, we can better serve customers in Taiwan and provide state-of-the-art cancer care for patients in Taiwan,” COOP founder CP Lin said in a prepared statement.

Late last month, Varian saw shares rise slightly after the medical device maker posted fiscal year 2018 second quarter earnings that beat The Street and saw profits and sales grow.

The post Varian acquires Taiwanese distributor Cooperative CL Enterprises appeared first on MassDevice.

Report: Amazon abandons drug distribution and supply plans

Amazon‘s (NSDQ:AMZN) Business division has dropped plans to sell and distribute pharmaceutical products to hospitals, according to a new report from CNBC.

The shift comes due to the online mega-retailer being unable to convince large hospital groups to change their purchasing process and break existing deals and relationships with distributors, according to the report.

Read the whole report on our sister site, Drug Delivery Business

 

The post Report: Amazon abandons drug distribution and supply plans appeared first on MassDevice.

Valeritas inks distro deal in Australia, New Zealand for V-Go insulin delivery device

Valeritas (NSDQ:VLRX) said today that it inked an exclusive distribution deal with AMSL Diabetes and NZMS Diabetes for the commercialization of its V-Go wearable insulin delivery device in Australia and New Zealand.

According to the terms of the agreement, AMSL Diabetes and NZMS Diabetes retain the right to promote, market and sell the V-Go device to clinics and patients, while Valeritas remains responsible for regulatory and manufacturing activities. Financial terms of the deal were not disclosed.

Get the full story at our sister site, Drug Delivery Business News.

The post Valeritas inks distro deal in Australia, New Zealand for V-Go insulin delivery device appeared first on MassDevice.

Smiths Medical inks distro deal for infusion therapy products

Smiths Medical plans to distribute its CADD infusion systems to non-hospital-based providers through a preferred partnership with Medical Specialties Distributors, the company reported today.

As part of its new distribution model, Smiths will also make its infusion pumps and sets available to providers outside of the hospital setting through InfuSystem (NYSE:INFU) and Integrated Medical Systems.

Get the full story at our sister site, Drug Delivery Business News.

The post Smiths Medical inks distro deal for infusion therapy products appeared first on MassDevice.

Cardiovascular Systems inks partnerships with OrbusNeich, Integer

  • These medtech companies raised the most VC last year

    Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving […]

  • Medtech stories we missed this week: Jan. 19, 2018

    From Privi Medical’s FDA clearance to OrthoXel getting FDA clearance and CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Privi Medical wins FDA nod for hemorrhoid device Privi Medical has received FDA clearance for its Instalief Hemorrhoids Treatment device, according to a Jan. 18 news […]

  • How blockchains could empower patients and secure data

    Blockchains are best known as the technology behind cryptocurrencies such as Bitcoin. But the founders of a young Atlanta-based company called Patientory think they could have another important use – securing health data and empowering patients along the way. Secure access to patient data is a major issue for the healthcare industry. Patients have a […]

  • Phillips-Medisize’s increased business to benefit Molex plant in Arkansas

    Phillips-Medisize today announced a doubling of production for an undisclosed fast-growing medical customer with a take-home diagnostic kit for cancer detection – with benefits for the plant that Phillips-Medisize’s parent Molex runs in Little Rock, Ark. Phillips-Medisize, which is based in Hudson, Wis., did not disclose the identity of the customer, which it described as a leader […]

  • GlobTek touts EAC-certified off-the-shelf power supplies for medical, other applications

    GlobTek is touting the wide variety of EAC-certified power supplies that it is offering for applications including medical, information technology equipment, household and more. A full list is available on the Northvale, N.J.–based company’s website.  EAC certification, formerly known as the Russian GOST-R certification, implements a new logo (EAC mark)  – and involves the implementation […]

  • Robotic spine surgery is getting a real-time image guide boost

    For the first time, surgeons at Johns Hopkins Hospital were able to harness real-time image guidance during a robotic spine surgery procedure to insert screws into a patient’s spine. The process offers a marked improvement over the accuracy of placement compared with other image-guided procedures. Dr. Nicholas Theodore – professor of neurosurgery at the Johns Hopkins University […]

  • Cardiovascular Systems inks partnerships with OrbusNeich, Integer

    Cardiovascular Systems (Nasdaq: CSII) announced today that it is expanding its product portfolio through new partnerships with OrbusNeich and Integer. The OrbusNeich partnership makes St. Paul, Minn.–based CSI the exclusive U.S. distributor of Hong Kong–based OrbusNeich‘s balloon products. The deal with Frisco, Texas–based Integer (NYSE: ITGR) involves Integer producing CSI-branded Zilient guidewires. Cardiovascular Systems CEO […]

  • FDA to expedite release of recall information

    Douglas Stearn, FDA When FDA identifies that a product it regulates violates the law, it protects the public by working with the manufacturer and distributors to facilitate the product’s recall (i.e., removal from the marketplace or product correction). Among other actions, FDA assures that the public is warned when products present the most significant public […]

  • IRS won’t enforce penalties on medical device tax

    The U.S. Internal Revenue Service yesterday said it won’t enforce penalties on companies making late payments on the medical device tax for the first three months of this year. The 2.3% excise tax on U.S. medical device revenues was in effect for two years before a two-year moratorium went into effect for 2016 and 2017. It went […]

  • Is tax reform good or bad for medical device companies?

    Medical device companies and others in the healthcare sector stand to benefit from the tax reform Congress passed at the end of 2017, but the picture isn’t entirely rosy, according to a new report from S&P Global Ratings. In many ways, the report offers a corrective to the bullish statements coming from corporate CEOs such […]

  • FDA releases top 3 medical device regulation goals

    FDA medical device regulators’ top priorities over the next three years include improving employee engagement, increasing simplicity and building collaborative communities, according to a new Strategic Priorities paper that FDA’s CDRH released today. The agency said the priorities further its overall goal of providing Americans with more timely access to the latest high-quality, safe and effective medical devices. […]

  • Dynatronics inks orthopedic distro deal

    Dynatronics said today it inked a distribution deal with Orthopedic Outfitters.

    Through the deal, Orthopedic Outfitters will distribute its Dynatronics division products, including the Dynatron Solaris Plus, ThermoStim Probe and 125B Portable Ultrasound across Northern California.

    “We are delighted to add Orthopedic Outfitters to our growing list of partnersOrthopedic Outfitters has built a reputation for excellent customer service and is recognized as a top dealer in the state of California.  They are an ideal partner to distribute our products in Northern California.  With this agreement, we continue to execute on one of the core pillars of our organic growth strategy – strengthening our domestic distribution,” Dynatronics chair & CEO Kelvyn Cullimore Jr. said in a prepared statement.

    “We are incredibly proud of the opportunity to partner with Dynatronics for this exciting new chapter of growth,” Orthopedic Outfitters CEO Jon Dunphy said in prepared remarks.

    “This agreement marks an exciting new milestone in the execution of our strategy for our legacy business. We have a great deal of respect for Jon and the business he has built over the years.  We look forward to the exciting work ahead as we strive to provide not only the best products, but also the best service in the industry,” sales & marketing VP Jeff Gephart said in a press release.

    Last April, Dynatronics said it raised $7.8 million in a new round of equity and mixed funding to cover its acquisition Hausman Industries assets, including physical therapy and athletic training products.

    The post Dynatronics inks orthopedic distro deal appeared first on MassDevice.

    NanoVibronix inks UK UroShield distro deal with IMS Ultrasound

    Share

    NanoVibronix

    NanoVibronix (NSDQ:NAOV) said today it inked a deal with the U.K.’s IMS Ultrasound to make it the exclusive U.K. distributor of its UroShield device, designed to prevent catheter-acquired urinary tract infections.

    The UroShield device from the Elmsford, N.Y.-based company is designed to decrease pain and discomfort associated with urinary catheter use while also preventing bacterial colonization and biofilm on indwelling catheters to reduce UTIs.

    “CAUTI is a major health concern in the UK and around the world, leading to extended hospital stays, increased costs, as well as increased patient mortality. We are excited to partner with NanoVibronix in order to bring UroShield to market in the UK, which we believe has enormous potential and could help save many lives. Given the strong supporting clinical data to date, we look forward to conducting an additional clinical trial in the UK with the support of NHS, which we believe will help garner even greater support from payors,” IMS Ultrasound managing director Andrew Wakeling said in a prepared statement.

    As part of the deal, NanoVibronix said that IMS Ultrasound will also be funding a clinical study in association with the U.K.’s National Health Service.

    “We are excited to report the addition of a significant European distributor partnership for UroShield following our recently announced preliminary clinical results, which demonstrate a material reduction in the rate of CAUTI. UroShield already has European marketing clearance, and this latest data is now helping us to attract the leading distributors across Europe. The fact IMS Ultrasound is willing to fully fund the planned clinical trial in the UK is strong validation of their interest and commitment to our UroShield product,” NanoVibronix CEO Brian Murphy said in a press release.

    Last month, NanoVibronix released interim results from a trial of its UroShield ultrasound device designed to prevent bacteria and biofilms from forming on urinary catheters, touting a low rate of CAUTIs.

    Elekta taps Brainlab as US stereotactic neurosurgery distro partner

    Share

    Elekta, Brainlab

    Elekta (STO:EKTA B) said today it inked an exclusive deal with Brainlab to make it the authorized distributor of Elekta’s stereotactic neurosurgery solutions.

    Through the deal, Brainlab will be the authorized distributor of Elekta’s Leksell Vantage stereotactic system which won CE Mark approval in the European Union this year. The system also has FDA 510(k) clearance and is commercially available in the US.

    Stereotactic neurosurgery is a minimally invasive approach to brain surgery designed to treat specific regions of the brain and spare surrounding healthy tissue, and is often used to implant deep brain stimulation leads or to perform lesioning of small brain targets for treating functional disorders.

    “Early adopters of the Vantage system are experiencing clinical and patient benefits from its multiple design innovations. These include stereotactic magnetic resonance imaging with fewer restrictions, easier target coordinate setting during surgery as well as improved anesthetic capabilities,” Elekta neuro portfolio VP Jesper Söderqvist said in a prepared statement.

    “We strive to make medical technology more impactful and accessible to physicians and their patients. By partnering with Elekta, we are increasing our reach and providing clinicians with advanced and innovative technology on the stereotactic neurosurgery market,” Brainlab functional & stereotactic neurosurgery VP Paolo Jelmoni said in a prepared release.

    The deal expands on an earlier distro deal the two companies signed in June that covered distribution in the European Union.

    “Brainlab shares our vision for improving care and outcomes for patients undergoing neurosurgical procedures. The expanded partnership with Brainlab, with a large and specialized sales and service team, to distribute Vantage in the United States gives us a strong position from which to realize the potential of the system to advance the care of patients undergoing stereotactic neurosurgery procedures,” Elekta NA exec VP Peter Gaccione said in a press release.

    In November, Elekta said it delayed the rollout of its Unity device, designed to combine magnetic resonance imaging with a linear accelerator for radiation therapy, saying it needed more time to finalize and validate the linac control system.